Osiris Therapeutics rises following 1Q results

Shares of stem cell therapy developer Osiris Therapeutics Inc. jumped Friday after the company reported a smaller-than-expected loss in the first quarter.

Here is the original post:

Osiris Therapeutics rises following 1Q results

Related Posts

Comments are closed.